Screener
TransMedics Group, Inc. TMDX Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Liver total revenue | 138,970 | 108,715 |
| Total United States OCS transplant revenue | 167,024 | 138,617 |
| All other countries | ||
| Lung revenue | 627 | 375 |
| Heart revenue | 5,011 | 3,550 |
| Liver revenue | 10 | 140 |
| Total all other countries OCS transplant revenue | 5,648 | 4,065 |
| Total OCS transplant revenue | $172,672 | $142,682 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TransMedics Group, Inc.'s business segments — revenue?
- TransMedics Group, Inc. (TMDX) reported business segments — revenue of $172.67M in Q1 2026.
- How has TransMedics Group, Inc.'s business segments — revenue changed year-over-year?
- TransMedics Group, Inc.'s business segments — revenue increased by 21.0% year-over-year, from $142.68M to $172.67M.
- What is the long-term trend for TransMedics Group, Inc.'s business segments — revenue?
- Over 3 years (2021 to 2025), TransMedics Group, Inc.'s business segments — revenue has grown at a 170.9% compound annual growth rate (CAGR), from $30.26M to $601.4M.
- What does business segments — revenue mean?
- This metric represents the total revenue generated from the sale and utilization of organ perfusion and monitoring systems designed to maintain donor organs in near-physiologic conditions. It captures the financial performance of the company's core technology platform used to replace traditional cold storage methods in transplant procedures. Growth in this segment reflects the successful clinical adoption and commercial expansion of advanced organ preservation solutions within the transplant market.
Ask your AI about TransMedics Group, Inc.'s business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude